Effectiveness of Subconjunctival Cyclosporine in Treatment of Acute Allergic Conjunctivitis in a Rat-Model

Amr Awara,1 Ayman Atiba,2 Duaa Helal,3 Hazem Elbedewy1 1Ophthalmology Department, Tanta University, Tanta, Egypt; 2Department of Surgery, Anesthesiology and Radiology, Faculty of Veterinary Medicine, Kafrelsheikh University, Kafrelsheikh, Egypt; 3Pathology Department, Tanta University, Tanta, EgyptC...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Awara A, Atiba A, Helal D, Elbedewy H
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/fa6e2818571b477594e2efe420b93a97
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fa6e2818571b477594e2efe420b93a97
record_format dspace
spelling oai:doaj.org-article:fa6e2818571b477594e2efe420b93a972021-12-02T09:59:25ZEffectiveness of Subconjunctival Cyclosporine in Treatment of Acute Allergic Conjunctivitis in a Rat-Model1177-5483https://doaj.org/article/fa6e2818571b477594e2efe420b93a972020-02-01T00:00:00Zhttps://www.dovepress.com/effectiveness-of-subconjunctival-cyclosporine-in-treatment-of-acute-al-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Amr Awara,1 Ayman Atiba,2 Duaa Helal,3 Hazem Elbedewy1 1Ophthalmology Department, Tanta University, Tanta, Egypt; 2Department of Surgery, Anesthesiology and Radiology, Faculty of Veterinary Medicine, Kafrelsheikh University, Kafrelsheikh, Egypt; 3Pathology Department, Tanta University, Tanta, EgyptCorrespondence: Amr AwaraOphthalmology Department, Tanta University, Tanta 31511, EgyptTel +2-01274005384Fax +20403415008Email amrawara@gmail.comBackground: Eye allergy is widely spread worldwide. The treatment includes topical anti-histamines, steroids and non-steroidal drugs. Steroids are the first choice by many ophthalmologists, but unfortunately they may cause serious side effects. Cyclosporine A (CsA) is an immunomodulator drug that can improve eye allergy and reduce the need for steroids; however, topical preparation of CsA is difficult because of the lipophilic nature of the drug.Methods: An experimental study included 16 rats with induced allergy were divided into 2 groups. Group 1: allergic non-treated (6 rats), and Group 2: allergic treated with 0.5 mL subconjunctival CsA 1% (10 rats). Half of each group was sacrificed at 24 hrs and the other half at 1 week. Conjunctival hyperemia and eosinophilic cell count were assessed at each time.Results: Group 2 (CsA treated) showed significantly lower hyperemia score and eosinophilic count at both 24 hrs and 1 week. No ocular complications were noted.Conclusion: Subconjunctival CsA was safe and effective in treating ocular allergy through improving conjunctival hyperemia and reducing eosinophilic cell count with no significant ocular side effects.Keywords: eye allergy, cyclosporine A, eosinophilia, subconjunctivalAwara AAtiba AHelal DElbedewy HDove Medical Pressarticleeye allergycyclosporine aeosinophiliasubconjunctival.OphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 14, Pp 431-435 (2020)
institution DOAJ
collection DOAJ
language EN
topic eye allergy
cyclosporine a
eosinophilia
subconjunctival.
Ophthalmology
RE1-994
spellingShingle eye allergy
cyclosporine a
eosinophilia
subconjunctival.
Ophthalmology
RE1-994
Awara A
Atiba A
Helal D
Elbedewy H
Effectiveness of Subconjunctival Cyclosporine in Treatment of Acute Allergic Conjunctivitis in a Rat-Model
description Amr Awara,1 Ayman Atiba,2 Duaa Helal,3 Hazem Elbedewy1 1Ophthalmology Department, Tanta University, Tanta, Egypt; 2Department of Surgery, Anesthesiology and Radiology, Faculty of Veterinary Medicine, Kafrelsheikh University, Kafrelsheikh, Egypt; 3Pathology Department, Tanta University, Tanta, EgyptCorrespondence: Amr AwaraOphthalmology Department, Tanta University, Tanta 31511, EgyptTel +2-01274005384Fax +20403415008Email amrawara@gmail.comBackground: Eye allergy is widely spread worldwide. The treatment includes topical anti-histamines, steroids and non-steroidal drugs. Steroids are the first choice by many ophthalmologists, but unfortunately they may cause serious side effects. Cyclosporine A (CsA) is an immunomodulator drug that can improve eye allergy and reduce the need for steroids; however, topical preparation of CsA is difficult because of the lipophilic nature of the drug.Methods: An experimental study included 16 rats with induced allergy were divided into 2 groups. Group 1: allergic non-treated (6 rats), and Group 2: allergic treated with 0.5 mL subconjunctival CsA 1% (10 rats). Half of each group was sacrificed at 24 hrs and the other half at 1 week. Conjunctival hyperemia and eosinophilic cell count were assessed at each time.Results: Group 2 (CsA treated) showed significantly lower hyperemia score and eosinophilic count at both 24 hrs and 1 week. No ocular complications were noted.Conclusion: Subconjunctival CsA was safe and effective in treating ocular allergy through improving conjunctival hyperemia and reducing eosinophilic cell count with no significant ocular side effects.Keywords: eye allergy, cyclosporine A, eosinophilia, subconjunctival
format article
author Awara A
Atiba A
Helal D
Elbedewy H
author_facet Awara A
Atiba A
Helal D
Elbedewy H
author_sort Awara A
title Effectiveness of Subconjunctival Cyclosporine in Treatment of Acute Allergic Conjunctivitis in a Rat-Model
title_short Effectiveness of Subconjunctival Cyclosporine in Treatment of Acute Allergic Conjunctivitis in a Rat-Model
title_full Effectiveness of Subconjunctival Cyclosporine in Treatment of Acute Allergic Conjunctivitis in a Rat-Model
title_fullStr Effectiveness of Subconjunctival Cyclosporine in Treatment of Acute Allergic Conjunctivitis in a Rat-Model
title_full_unstemmed Effectiveness of Subconjunctival Cyclosporine in Treatment of Acute Allergic Conjunctivitis in a Rat-Model
title_sort effectiveness of subconjunctival cyclosporine in treatment of acute allergic conjunctivitis in a rat-model
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/fa6e2818571b477594e2efe420b93a97
work_keys_str_mv AT awaraa effectivenessofsubconjunctivalcyclosporineintreatmentofacuteallergicconjunctivitisinaratmodel
AT atibaa effectivenessofsubconjunctivalcyclosporineintreatmentofacuteallergicconjunctivitisinaratmodel
AT helald effectivenessofsubconjunctivalcyclosporineintreatmentofacuteallergicconjunctivitisinaratmodel
AT elbedewyh effectivenessofsubconjunctivalcyclosporineintreatmentofacuteallergicconjunctivitisinaratmodel
_version_ 1718397863437795328